Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. IN8bio Inc is a clinical-stage biotechnology company. It is focused on developing innovative therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells.
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.0252 | -9.9604743083 | 0.253 | 0.2565 | 0.2173 | 1481966 | 0.24085086 | CS |
| 4 | -0.0859 | -27.3828498566 | 0.3137 | 0.3286 | 0.2173 | 2526021 | 0.26989422 | CS |
| 12 | -0.0032 | -1.38528138528 | 0.231 | 0.4177 | 0.2173 | 5991023 | 0.30026982 | CS |
| 26 | -0.0922 | -28.8125 | 0.32 | 0.5566 | 0.217 | 3259028 | 0.31508753 | CS |
| 52 | -1.0122 | -81.6290322581 | 1.24 | 1.74 | 0.217 | 1807588 | 0.3897864 | CS |
| 156 | -2.9722 | -92.88125 | 3.2 | 4.9799 | 0.217 | 1114481 | 1.376134 | CS |
| 260 | -9.7722 | -97.722 | 10 | 10.319 | 0.217 | 930871 | 1.42114356 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
